Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs 10X Genomics Inc (TXG) Price & Performance

Norwegian Cruise Line Holdings LtdTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Norwegian Cruise Line Holdings Ltd vs 10X Genomics Inc — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $19.47 (market cap $8.95B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Norwegian Cruise Line Holdings Ltd is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals.

NCLHTXG
Market Cap
$8.95B$5.48B
Sector
Consumer CyclicalHealth
52-Week High
$26.94$45.80
52-Week Low
$14.79$11.34
Enterprise Value
$23.92B$5.02B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG